Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Abramson VG"'
Autor:
Abramson RG, Arlinghaus LR, Weis JA, Li X, Dula AN, Chekmenev EY, Smith SA, Miga MI, Abramson VG, Yankeelov TE
Publikováno v:
Breast Cancer: Targets and Therapy, Vol 2012, Iss default, Pp 139-154 (2012)
Richard G Abramson,1,2,9 Lori R Arlinghaus,1,2 Jared A Weis,1,2 Xia Li,1,2 Adrienne N Dula,1,2 Eduard Y Chekmenev,1–4,9 Seth A Smith,1–3,5 Michael I Miga,1–3,6 Vandana G Abramson,7,9 Thomas E Yankeelov1–3,5,8,91Institute of Imaging Science, 2
Externí odkaz:
https://doaj.org/article/5667bfc89e4645fe95393904b835dedc
Autor:
Mezzanotte-Sharpe J; Vanderbilt University Medical Center, 2220 Pierce Avenue, 777 PRB, Nashville, TN, 37232-6307, USA., ONeill A; Dana-Farber Cancer Institute, Boston, MA, USA., Mayer IA; Vanderbilt University Medical Center, 2220 Pierce Avenue, 777 PRB, Nashville, TN, 37232-6307, USA., Arteaga CL; UT Southwestern/Simmons Cancer Center, Dallas, TX, USA., Yang XJ; Northwestern University, Chicago, IL, USA., Wagner LI; Wake Forest University Health Sciences, Winston Salem, NC, USA., Cella D; Northwestern University, Chicago, IL, USA., Meropol NJ; Case Western Reserve University, Cleveland, OH, USA., Alpaugh RK; Fox Chase Cancer Center, Philadelphia, PA, USA., Saphner TJ; Aurora Health Care- Aurora Cancer Care, Two Rivers, Wl, USA., Swaney RE; Denver Health Medical Center, Denver, CO, USA., Hoelzer KL; Memorial Medical Center, Springfield, IL, USA., Gradishar WJ; Northwestern University, Chicago, IL, USA., Abramson VG; Vanderbilt University Medical Center, 2220 Pierce Avenue, 777 PRB, Nashville, TN, 37232-6307, USA., Sundaram PK; Columbus NCORP, Columbus, OH, USA., Jilani SZ; Good Samaritan Hospital, Dayton, OH, USA., Perez EA; Mayo Clinic, Jacksonville, FL, USA., Lin NU; Dana-Farber Cancer Institute, Boston, MA, USA., Jahanzeb M; University of Miami, Deerfield Beach, FL, USA., Wolff AC; Johns Hopkins University, Baltimore, MD, USA., Sledge GW; Stanford Cancer Institute, Stanford, CA, USA., Reid SA; Vanderbilt University Medical Center, 2220 Pierce Avenue, 777 PRB, Nashville, TN, 37232-6307, USA. sonya.reid@vumc.org.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Sep; Vol. 207 (2), pp. 275-282. Date of Electronic Publication: 2024 Jul 05.
Autor:
Waks AG; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA., Chen EL; Brigham and Women's Hospital, Boston, MA., Graham N; Data Sciences, Dana-Farber Cancer Institute, Boston, MA., Frey AM; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA., Almeida K; Pharmacy and Clinical Support, Dana-Farber Cancer Institute, Boston, MA., Attaya V; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Current Affiliation: Olema Oncology, San Francisco, CA., Ryding C; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Abbass I; Genentech, Inc, South San Francisco, CA., Fung A; Genentech, Inc, South San Francisco, CA., Sussell J; Genentech, Inc, South San Francisco, CA., Cortazar P; Genentech, Inc, South San Francisco, CA., Harvey C; Pharmacy and Clinical Support, Dana-Farber Cancer Institute, Boston, MA., Leth D; Pharmacy and Clinical Support, Dana-Farber Cancer Institute, Boston, MA., Faggen M; Dana-Farber Brigham Cancer Center in Clinical Affiliation With South Shore Hospital, Weymouth, MA., Sinclair N; Dana-Farber Brigham Cancer Center-Foxborough and Milford, Foxborough, MA., Walsh J; Dana-Farber/New Hampshire Oncology-Hematology, Londonderry, NH., Tung N; Harvard Medical School, Boston, MA.; Beth Israel Deaconess Medical Center, Boston, MA., Sinclair S; Eastern Maine Medical Center, Brewer, ME., Lo S; Bennett Cancer Center, Stamford Health, Stamford, CT., Yardley D; Sarah Cannon Research Institute, Nashville, TN., Valero V; The University of Texas MD Anderson Cancer Center, Houston, TX., Meisel J; Winship Cancer Institute at Emory University, Atlanta, GA., Ballinger TJ; Indiana University School of Medicine, Indianapolis, IN., Adams S; Perlmutter Cancer Center, NYU Langone Health, New York, NY., Carey LA; Department of Medicine, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC., Rauch JK; UNC Health, Garner, NC., Abramson VG; Vanderbilt University Medical Center, Nashville, TN., Williams NO; Ohio State University Wexner Medical Center, Columbus, OH., Chen WY; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA., Leone JP; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA., Schumer ST; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA., Tayob N; Harvard Medical School, Boston, MA.; Data Sciences, Dana-Farber Cancer Institute, Boston, MA., Tolaney SM; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.
Publikováno v:
JCO oncology practice [JCO Oncol Pract] 2024 Jul 19, pp. OP2400021. Date of Electronic Publication: 2024 Jul 19.
Autor:
Wescott EC; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee., Sun X; Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee., Gonzalez-Ericsson P; Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Hanna A; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Taylor BC; Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee., Sanchez V; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Bronzini J; Department of Biological Sciences, Vanderbilt University, Nashville, Tennessee., Opalenik SR; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Sanders ME; Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Wulfkuhle J; Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia., Gallagher RI; Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia., Gomez H; Department of Medical Oncology, Instituto Nacional de Enfermedades Neoplásicas, Lima, Perú., Isaacs C; Division of Hematology-Oncology, Department of Medicine, Georgetown University, Washington, District of Columbia., Bharti V; Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, Tennessee., Wilson JT; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee.; Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, Tennessee., Ballinger TJ; Division of Hematology and Oncology, Indiana University School of Medicine, Indianapolis, Indiana., Santa-Maria CA; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland., Shah PD; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Dees EC; Department of Medicine, School of Medicine, University of North Carolina, Chapel Hill, North Carolina., Lehmann BD; Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Abramson VG; Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Hirst GL; Department of Surgery, University of California San Francisco, San Francisco, California., Brown Swigart L; Department of Laboratory Medicine, University of California San Francisco, San Francisco, California., van ˈt Veer LJ; Department of Laboratory Medicine, University of California San Francisco, San Francisco, California., Esserman LJ; Department of Surgery, University of California San Francisco, San Francisco, California., Petricoin EF; Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia., Pietenpol JA; Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland.; Department of Biochemistry, Vanderbilt University Medical Center, Nashville, Tennessee., Balko JM; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee.; Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.; Cancer Biology Program, Vanderbilt University, Nashville, Tennessee.
Publikováno v:
Cancer research communications [Cancer Res Commun] 2024 Apr 24; Vol. 4 (4), pp. 1120-1134.
Autor:
Balbach ML; Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, Tennessee., Sherry AD; Department of Radiation Oncology, Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas., Rexer BN; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Abramson VG; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Niermann KJ; Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, Tennessee., Johnson CR; Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, Tennessee., Park BH; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Mayer IA; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Chakravarthy AB; Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, Tennessee. Electronic address: bapsi.chak@vumc.org.
Publikováno v:
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2024 Apr 01; Vol. 118 (5), pp. 1262-1270. Date of Electronic Publication: 2023 Jul 16.
Autor:
Taylor BC; Cancer Biology Program, Vanderbilt University, Nashville, Tennessee., Sun X; Cancer Biology Program, Vanderbilt University, Nashville, Tennessee., Gonzalez-Ericsson PI; Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.; Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee., Sanchez V; Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee., Sanders ME; Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.; Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee., Wescott EC; Department of Pathology, Microbiology, and Immunology, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee., Opalenik SR; Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee., Hanna A; Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee., Chou ST; Cancer Biology Program, Vanderbilt University, Nashville, Tennessee., Van Kaer L; Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.; Department of Pathology, Microbiology, and Immunology, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee., Gomez H; Department of Medical Oncology, Instituto Nacional de Enfermedades Neoplásicas, Lima, Perú., Isaacs C; Division of Hematology-Oncology, Department of Medicine, Georgetown University, Washington, District of Columbia., Ballinger TJ; Division of Hematology and Oncology, Indiana University School of Medicine, Indianapolis, Indiana., Santa-Maria CA; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland., Shah PD; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Dees EC; Department of Medicine, School of Medicine, University of North Carolina, Chapel Hill, North Carolina., Lehmann BD; Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.; Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee., Abramson VG; Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.; Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee., Pietenpol JA; Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.; Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.; Department of Biochemistry, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee., Balko JM; Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.; Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.; Department of Pathology, Microbiology, and Immunology, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.
Publikováno v:
Cancer discovery [Cancer Discov] 2024 Feb 08; Vol. 14 (2), pp. 290-307.
Autor:
Lehmann BD; Department of Medicine, Vanderbilt University, Nashville, Tennessee.; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Tennessee., Abramson VG; Department of Medicine, Vanderbilt University, Nashville, Tennessee.; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Tennessee., Dees EC; Department of Medicine and Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill., Shah PD; Department of Medicine, University of Pennsylvania, Philadelphia., Ballinger TJ; Department of Medicine, Indiana University, Indianapolis., Isaacs C; Department of Medical Oncology, Lombardi Cancer Center, Georgetown University, Washington, DC., Santa-Maria CA; Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland., An H; Department of Otolaryngology, Vanderbilt University Medical Center, Nashville, Tennessee., Gonzalez-Ericsson PI; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Tennessee.; Breast Cancer Research Program, Vanderbilt University Medical Center, Nashville, Tennessee., Sanders ME; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Tennessee.; Department of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, Tennessee., Newsom KC; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Tennessee., Abramson RG; Department of Biomedical Engineering, Vanderbilt University School of Engineering, Nashville, Tennessee., Sheng Q; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee.; Center for Quantitative Sciences, Vanderbilt University Medical Center, Nashville, Tennessee., Hsu CY; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee.; Center for Quantitative Sciences, Vanderbilt University Medical Center, Nashville, Tennessee., Shyr Y; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee.; Center for Quantitative Sciences, Vanderbilt University Medical Center, Nashville, Tennessee., Wolff AC; Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland., Pietenpol JA; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Tennessee.; Department of Biochemistry, Vanderbilt University, Nashville, Tennessee.
Publikováno v:
JAMA oncology [JAMA Oncol] 2024 Feb 01; Vol. 10 (2), pp. 193-201.
Autor:
Lenz L; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA., Neff C; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA., Solimeno C; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA., Cogan ES; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA., Abramson VG; Vanderbilt University Medical Center, Nashville, TN, USA., Boughey JC; Mayo Clinic, Rochester, MN, USA., Falkson C; University of Rochester Medical Center, Rochester, NY, USA., Goetz MP; Mayo Clinic, Rochester, MN, USA., Ford JM; Stanford University School of Medicine, Stanford, CA, USA., Gradishar WJ; Northwestern University, Chicago, IL, USA., Jankowitz RC; University of Pennsylvania, Philadelphia, PA, USA., Kaklamani VG; University of Texas Health Science Center at San Antonio, San Antonio, TX, USA., Marcom PK; Duke University, Durham, NC, USA., Richardson AL; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA., Storniolo AM; Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN, USA., Tung NM; Beth Israel Deaconess Medical Center, Boston, MA, USA., Vinayak S; University of Washington, Seattle, WA, USA.; Fred Hutchinson Cancer Research Center, 15. AstraZeneca, Seattle, WA, USA., Hodgson DR; AstraZeneca, Cambridge, UK., Lai Z; AstraZeneca, Boston, MA, USA., Dearden S; AstraZeneca, Cambridge, UK., Hennessy BT; Royal College of Surgeons in Ireland, Dublin, Ireland., Mayer EL; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Mills GB; Oregon Health & Science University, Portland, OR, USA., Slavin TP; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA., Gutin A; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA., Connolly RM; Cancer Research @UCC, University College Cork, Cork, Ireland., Telli ML; Stanford University School of Medicine, Stanford, CA, USA., Stearns V; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA., Lanchbury JS; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA., Timms KM; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA. ktimms@myriad.com.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2023 Nov; Vol. 202 (1), pp. 191-201. Date of Electronic Publication: 2023 Aug 17.
Autor:
Hennessy MA; Cancer Research @UCC, Cork, Ireland; roisin.connolly@ucc.ie 122108045@umail.ucc.ie., Leal JP; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland., Huang CY; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland.; University of California, San Francisco, California., Solnes LB; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland., Denbow R; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland., Abramson VG; Vanderbilt University, Nashville, Tennessee., Carey LA; University of North Carolina, Chapel Hill, North Carolina., Liu MC; Mayo Clinic, Rochester, Minnesota., Rimawi M; Baylor College of Medicine, Houston, Texas., Specht J; University of Washington, Seattle, Washington., Storniolo AM; Melvin and Bren Simon Comprehensive Cancer Center, Indiana University, Indianapolis, Indiana., Valero V; M.D. Anderson Cancer Center, Houston, Texas., Vaklavas C; University of Alabama, Birmingham, Alabama., Winer EP; Yale Cancer Center, New Haven, Connecticut; and., Krop IE; Yale Cancer Center, New Haven, Connecticut; and., Wolff AC; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland., Cimino-Mathews A; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland., Wahl RL; Washington University, St. Louis, Missouri., Stearns V; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland., Connolly RM; Cancer Research @UCC, Cork, Ireland; roisin.connolly@ucc.ie 122108045@umail.ucc.ie.; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland.
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2023 Nov; Vol. 64 (11), pp. 1690-1696. Date of Electronic Publication: 2023 Aug 31.
Autor:
Parsons HA; Medical Oncology, Dana-Farber Cancer Institute, Boston; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston; Harvard Medical School, Boston. Electronic address: Heather_Parsons@dfci.harvard.edu., Blewett T; Broad Institute of MIT and Harvard, Cambridge., Chu X; Data Science, Dana-Farber Cancer Institute, Boston., Sridhar S; Broad Institute of MIT and Harvard, Cambridge., Santos K; Medical Oncology, Dana-Farber Cancer Institute, Boston., Xiong K; Broad Institute of MIT and Harvard, Cambridge., Abramson VG; Vanderbilt-Ingram Cancer Center, Nashville., Patel A; Medical Oncology, Dana-Farber Cancer Institute, Boston., Cheng J; Broad Institute of MIT and Harvard, Cambridge., Brufsky A; University of Pittsburgh School of Medicine, Pittsburgh., Rhoades J; Broad Institute of MIT and Harvard, Cambridge., Force J; Duke Cancer Center, Durham., Liu R; Broad Institute of MIT and Harvard, Cambridge., Traina TA; Memorial Sloan Kettering Cancer Center, New York., Carey LA; The University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill., Rimawi MF; Baylor College of Medicine Dan L. Duncan Comprehensive Cancer Center, Houston., Miller KD; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis., Stearns V; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore., Specht J; Seattle Cancer Care Alliance, Seattle., Falkson C; The University of Alabama at Birmingham, Birmingham., Burstein HJ; Medical Oncology, Dana-Farber Cancer Institute, Boston; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston; Harvard Medical School, Boston., Wolff AC; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore., Winer EP; Medical Oncology, Dana-Farber Cancer Institute, Boston; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston; Harvard Medical School, Boston., Tayob N; Data Science, Dana-Farber Cancer Institute, Boston., Krop IE; Medical Oncology, Dana-Farber Cancer Institute, Boston; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston; Harvard Medical School, Boston., Makrigiorgos GM; Radiation Oncology, Dana-Farber Cancer Institute, Boston, USA., Golub TR; Broad Institute of MIT and Harvard, Cambridge., Mayer EL; Medical Oncology, Dana-Farber Cancer Institute, Boston; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston; Harvard Medical School, Boston. Electronic address: Erica_Mayer@dfci.harvard.edu., Adalsteinsson VA; Broad Institute of MIT and Harvard, Cambridge. Electronic address: viktor@broadinstitute.org.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2023 Oct; Vol. 34 (10), pp. 899-906. Date of Electronic Publication: 2023 Aug 18.